4658-301: An Open Label, Multi-Center, 48-Week Study with a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy

Project: Research project

Project Details

StatusFinished
Effective start/end date11/1/14 → 11/6/20

Funding

  • Sarepta Therapeutics, Inc.